Plague Therapeutics Market, Global Outlook and Forecast 2022-2028

February 2022 | 118 pages | ID: P447CC2AA56EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Plague Therapeutics in Global, including the following market information:

Global Plague Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Plague Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Plague Therapeutics include CordenPharma, Cipher Pharmaceuticals, Pfizer, Bayer HealthCare, Eli Lilly, Achaogen, Aurobindo Pharma, GlaxoSmithKline and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plague Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plague Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Plague Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Vaccine
• Drugs

Global Plague Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Plague Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Others

Global Plague Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Plague Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Plague Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Plague Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• CordenPharma
• Cipher Pharmaceuticals
• Pfizer
• Bayer HealthCare
• Eli Lilly
• Achaogen
• Aurobindo Pharma
• GlaxoSmithKline
• Bristol-Myers Squibb
• Aspen Pharmacare
• Biocon
• Astellas Pharma
• Melinta Therapeutics
• Basilea Pharmaceutica
• Allergan
• Abbott
• AstraZeneca
• AmpliPhi Biosciences
• Actelion Pharmaceuticals
• Chiesi Farmaceutici
• Exoxemis
• Merck
• DynPort Vaccine Company LLC

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Plague Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Plague Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PLAGUE THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Plague Therapeutics Market Size: 2021 VS 2028
2.2 Global Plague Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Plague Therapeutics Players in Global Market
3.2 Top Global Plague Therapeutics Companies Ranked by Revenue
3.3 Global Plague Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Plague Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Plague Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plague Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Plague Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Plague Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Plague Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Vaccine
  4.1.3 Drugs
4.2 By Type - Global Plague Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Plague Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Plague Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Plague Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Plague Therapeutics Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Others
5.2 By Application - Global Plague Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Plague Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Plague Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Plague Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Plague Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Plague Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Plague Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Plague Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Plague Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Plague Therapeutics Revenue, 2017-2028
  6.3.2 US Plague Therapeutics Market Size, 2017-2028
  6.3.3 Canada Plague Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Plague Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Plague Therapeutics Revenue, 2017-2028
  6.4.2 Germany Plague Therapeutics Market Size, 2017-2028
  6.4.3 France Plague Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Plague Therapeutics Market Size, 2017-2028
  6.4.5 Italy Plague Therapeutics Market Size, 2017-2028
  6.4.6 Russia Plague Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Plague Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Plague Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Plague Therapeutics Revenue, 2017-2028
  6.5.2 China Plague Therapeutics Market Size, 2017-2028
  6.5.3 Japan Plague Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Plague Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Plague Therapeutics Market Size, 2017-2028
  6.5.6 India Plague Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Plague Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Plague Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Plague Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Plague Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Plague Therapeutics Market Size, 2017-2028
  6.7.3 Israel Plague Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Plague Therapeutics Market Size, 2017-2028
  6.7.5 UAE Plague Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 CordenPharma
  7.1.1 CordenPharma Corporate Summary
  7.1.2 CordenPharma Business Overview
  7.1.3 CordenPharma Plague Therapeutics Major Product Offerings
  7.1.4 CordenPharma Plague Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 CordenPharma Key News
7.2 Cipher Pharmaceuticals
  7.2.1 Cipher Pharmaceuticals Corporate Summary
  7.2.2 Cipher Pharmaceuticals Business Overview
  7.2.3 Cipher Pharmaceuticals Plague Therapeutics Major Product Offerings
  7.2.4 Cipher Pharmaceuticals Plague Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Cipher Pharmaceuticals Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Plague Therapeutics Major Product Offerings
  7.3.4 Pfizer Plague Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Pfizer Key News
7.4 Bayer HealthCare
  7.4.1 Bayer HealthCare Corporate Summary
  7.4.2 Bayer HealthCare Business Overview
  7.4.3 Bayer HealthCare Plague Therapeutics Major Product Offerings
  7.4.4 Bayer HealthCare Plague Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Bayer HealthCare Key News
7.5 Eli Lilly
  7.5.1 Eli Lilly Corporate Summary
  7.5.2 Eli Lilly Business Overview
  7.5.3 Eli Lilly Plague Therapeutics Major Product Offerings
  7.5.4 Eli Lilly Plague Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Eli Lilly Key News
7.6 Achaogen
  7.6.1 Achaogen Corporate Summary
  7.6.2 Achaogen Business Overview
  7.6.3 Achaogen Plague Therapeutics Major Product Offerings
  7.6.4 Achaogen Plague Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Achaogen Key News
7.7 Aurobindo Pharma
  7.7.1 Aurobindo Pharma Corporate Summary
  7.7.2 Aurobindo Pharma Business Overview
  7.7.3 Aurobindo Pharma Plague Therapeutics Major Product Offerings
  7.7.4 Aurobindo Pharma Plague Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Aurobindo Pharma Key News
7.8 GlaxoSmithKline
  7.8.1 GlaxoSmithKline Corporate Summary
  7.8.2 GlaxoSmithKline Business Overview
  7.8.3 GlaxoSmithKline Plague Therapeutics Major Product Offerings
  7.8.4 GlaxoSmithKline Plague Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline Key News
7.9 Bristol-Myers Squibb
  7.9.1 Bristol-Myers Squibb Corporate Summary
  7.9.2 Bristol-Myers Squibb Business Overview
  7.9.3 Bristol-Myers Squibb Plague Therapeutics Major Product Offerings
  7.9.4 Bristol-Myers Squibb Plague Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Bristol-Myers Squibb Key News
7.10 Aspen Pharmacare
  7.10.1 Aspen Pharmacare Corporate Summary
  7.10.2 Aspen Pharmacare Business Overview
  7.10.3 Aspen Pharmacare Plague Therapeutics Major Product Offerings
  7.10.4 Aspen Pharmacare Plague Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Aspen Pharmacare Key News
7.11 Biocon
  7.11.1 Biocon Corporate Summary
  7.11.2 Biocon Business Overview
  7.11.3 Biocon Plague Therapeutics Major Product Offerings
  7.11.4 Biocon Plague Therapeutics Revenue in Global Market (2017-2022)
  7.11.5 Biocon Key News
7.12 Astellas Pharma
  7.12.1 Astellas Pharma Corporate Summary
  7.12.2 Astellas Pharma Business Overview
  7.12.3 Astellas Pharma Plague Therapeutics Major Product Offerings
  7.12.4 Astellas Pharma Plague Therapeutics Revenue in Global Market (2017-2022)
  7.12.5 Astellas Pharma Key News
7.13 Melinta Therapeutics
  7.13.1 Melinta Therapeutics Corporate Summary
  7.13.2 Melinta Therapeutics Business Overview
  7.13.3 Melinta Therapeutics Plague Therapeutics Major Product Offerings
  7.13.4 Melinta Therapeutics Plague Therapeutics Revenue in Global Market (2017-2022)
  7.13.5 Melinta Therapeutics Key News
7.14 Basilea Pharmaceutica
  7.14.1 Basilea Pharmaceutica Corporate Summary
  7.14.2 Basilea Pharmaceutica Business Overview
  7.14.3 Basilea Pharmaceutica Plague Therapeutics Major Product Offerings
  7.14.4 Basilea Pharmaceutica Plague Therapeutics Revenue in Global Market (2017-2022)
  7.14.5 Basilea Pharmaceutica Key News
7.15 Allergan
  7.15.1 Allergan Corporate Summary
  7.15.2 Allergan Business Overview
  7.15.3 Allergan Plague Therapeutics Major Product Offerings
  7.15.4 Allergan Plague Therapeutics Revenue in Global Market (2017-2022)
  7.15.5 Allergan Key News
7.16 Abbott
  7.16.1 Abbott Corporate Summary
  7.16.2 Abbott Business Overview
  7.16.3 Abbott Plague Therapeutics Major Product Offerings
  7.16.4 Abbott Plague Therapeutics Revenue in Global Market (2017-2022)
  7.16.5 Abbott Key News
7.17 AstraZeneca
  7.17.1 AstraZeneca Corporate Summary
  7.17.2 AstraZeneca Business Overview
  7.17.3 AstraZeneca Plague Therapeutics Major Product Offerings
  7.17.4 AstraZeneca Plague Therapeutics Revenue in Global Market (2017-2022)
  7.17.5 AstraZeneca Key News
7.18 AmpliPhi Biosciences
  7.18.1 AmpliPhi Biosciences Corporate Summary
  7.18.2 AmpliPhi Biosciences Business Overview
  7.18.3 AmpliPhi Biosciences Plague Therapeutics Major Product Offerings
  7.18.4 AmpliPhi Biosciences Plague Therapeutics Revenue in Global Market (2017-2022)
  7.18.5 AmpliPhi Biosciences Key News
7.19 Actelion Pharmaceuticals
  7.19.1 Actelion Pharmaceuticals Corporate Summary
  7.19.2 Actelion Pharmaceuticals Business Overview
  7.19.3 Actelion Pharmaceuticals Plague Therapeutics Major Product Offerings
  7.19.4 Actelion Pharmaceuticals Plague Therapeutics Revenue in Global Market (2017-2022)
  7.19.5 Actelion Pharmaceuticals Key News
7.20 Chiesi Farmaceutici
  7.20.1 Chiesi Farmaceutici Corporate Summary
  7.20.2 Chiesi Farmaceutici Business Overview
  7.20.3 Chiesi Farmaceutici Plague Therapeutics Major Product Offerings
  7.20.4 Chiesi Farmaceutici Plague Therapeutics Revenue in Global Market (2017-2022)
  7.20.5 Chiesi Farmaceutici Key News
7.21 Exoxemis
  7.21.1 Exoxemis Corporate Summary
  7.21.2 Exoxemis Business Overview
  7.21.3 Exoxemis Plague Therapeutics Major Product Offerings
  7.21.4 Exoxemis Plague Therapeutics Revenue in Global Market (2017-2022)
  7.21.5 Exoxemis Key News
7.22 Merck
  7.22.1 Merck Corporate Summary
  7.22.2 Merck Business Overview
  7.22.3 Merck Plague Therapeutics Major Product Offerings
  7.22.4 Merck Plague Therapeutics Revenue in Global Market (2017-2022)
  7.22.5 Merck Key News
7.23 DynPort Vaccine Company LLC
  7.23.1 DynPort Vaccine Company LLC Corporate Summary
  7.23.2 DynPort Vaccine Company LLC Business Overview
  7.23.3 DynPort Vaccine Company LLC Plague Therapeutics Major Product Offerings
  7.23.4 DynPort Vaccine Company LLC Plague Therapeutics Revenue in Global Market (2017-2022)
  7.23.5 DynPort Vaccine Company LLC Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Plague Therapeutics Market Opportunities & Trends in Global Market
Table 2. Plague Therapeutics Market Drivers in Global Market
Table 3. Plague Therapeutics Market Restraints in Global Market
Table 4. Key Players of Plague Therapeutics in Global Market
Table 5. Top Plague Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Plague Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Plague Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Plague Therapeutics Product Type
Table 9. List of Global Tier 1 Plague Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plague Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Plague Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Plague Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Plague Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Plague Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Plague Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Plague Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Plague Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Plague Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Plague Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Plague Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Plague Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Plague Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Plague Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Plague Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Plague Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Plague Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Plague Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Plague Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Plague Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. CordenPharma Corporate Summary
Table 31. CordenPharma Plague Therapeutics Product Offerings
Table 32. CordenPharma Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Cipher Pharmaceuticals Corporate Summary
Table 34. Cipher Pharmaceuticals Plague Therapeutics Product Offerings
Table 35. Cipher Pharmaceuticals Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Plague Therapeutics Product Offerings
Table 38. Pfizer Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Bayer HealthCare Corporate Summary
Table 40. Bayer HealthCare Plague Therapeutics Product Offerings
Table 41. Bayer HealthCare Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Eli Lilly Corporate Summary
Table 43. Eli Lilly Plague Therapeutics Product Offerings
Table 44. Eli Lilly Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Achaogen Corporate Summary
Table 46. Achaogen Plague Therapeutics Product Offerings
Table 47. Achaogen Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Aurobindo Pharma Corporate Summary
Table 49. Aurobindo Pharma Plague Therapeutics Product Offerings
Table 50. Aurobindo Pharma Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Plague Therapeutics Product Offerings
Table 53. GlaxoSmithKline Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Plague Therapeutics Product Offerings
Table 56. Bristol-Myers Squibb Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Aspen Pharmacare Corporate Summary
Table 58. Aspen Pharmacare Plague Therapeutics Product Offerings
Table 59. Aspen Pharmacare Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Biocon Corporate Summary
Table 61. Biocon Plague Therapeutics Product Offerings
Table 62. Biocon Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. Astellas Pharma Corporate Summary
Table 64. Astellas Pharma Plague Therapeutics Product Offerings
Table 65. Astellas Pharma Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Melinta Therapeutics Corporate Summary
Table 67. Melinta Therapeutics Plague Therapeutics Product Offerings
Table 68. Melinta Therapeutics Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. Basilea Pharmaceutica Corporate Summary
Table 70. Basilea Pharmaceutica Plague Therapeutics Product Offerings
Table 71. Basilea Pharmaceutica Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 72. Allergan Corporate Summary
Table 73. Allergan Plague Therapeutics Product Offerings
Table 74. Allergan Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 75. Abbott Corporate Summary
Table 76. Abbott Plague Therapeutics Product Offerings
Table 77. Abbott Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 78. AstraZeneca Corporate Summary
Table 79. AstraZeneca Plague Therapeutics Product Offerings
Table 80. AstraZeneca Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 81. AmpliPhi Biosciences Corporate Summary
Table 82. AmpliPhi Biosciences Plague Therapeutics Product Offerings
Table 83. AmpliPhi Biosciences Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 84. Actelion Pharmaceuticals Corporate Summary
Table 85. Actelion Pharmaceuticals Plague Therapeutics Product Offerings
Table 86. Actelion Pharmaceuticals Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 87. Chiesi Farmaceutici Corporate Summary
Table 88. Chiesi Farmaceutici Plague Therapeutics Product Offerings
Table 89. Chiesi Farmaceutici Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 90. Exoxemis Corporate Summary
Table 91. Exoxemis Plague Therapeutics Product Offerings
Table 92. Exoxemis Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 93. Merck Corporate Summary
Table 94. Merck Plague Therapeutics Product Offerings
Table 95. Merck Plague Therapeutics Revenue (US$, Mn), (2017-2022)
Table 96. DynPort Vaccine Company LLC Corporate Summary
Table 97. DynPort Vaccine Company LLC Plague Therapeutics Product Offerings
Table 98. DynPort Vaccine Company LLC Plague Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Plague Therapeutics Segment by Type in 2021
Figure 2. Plague Therapeutics Segment by Application in 2021
Figure 3. Global Plague Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Plague Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Plague Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plague Therapeutics Revenue in 2021
Figure 8. By Type - Global Plague Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Plague Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Plague Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Plague Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Plague Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Plague Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Plague Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Plague Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Plague Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. CordenPharma Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Cipher Pharmaceuticals Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bayer HealthCare Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Eli Lilly Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Achaogen Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aurobindo Pharma Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Aspen Pharmacare Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Biocon Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Astellas Pharma Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Melinta Therapeutics Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Basilea Pharmaceutica Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Allergan Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Abbott Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AstraZeneca Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. AmpliPhi Biosciences Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Actelion Pharmaceuticals Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Chiesi Farmaceutici Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Exoxemis Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Merck Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. DynPort Vaccine Company LLC Plague Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)